← All trials
NCT04031859
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 10, 2018
- Primary completion
- Jul 14, 2019
- Completion date
- Jul 22, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 224
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of Saudi ArabiaLead sponsor
- University of Science MalaysiaCollaborator
- University of Science MalaysiaOverall official - principal investigator
- Government of Saudi ArabiaReponsible party - principal investigator
- Government of Saudi ArabiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.